发明名称 SYNERGISTIC COMBINATION FOR THE TREATMENT OF DIABETIC NEUROPATHY
摘要 <p>This invention is based on an efficient treatment of diabetic neurotherapy. The drug combination is made up three ingredients. These are taurine, folic acid and methylcobalamin. These are working as a synergistic compound for the treatment of diabetic neurotherapy the concentration of these compounds are Methylcobalamin is 1500 microgram per tablet, taurine is 500 mg per tablet and folic acid is 5 mg per tablet. In this combination taurine is used for anxiolytic effect and may act as a modulator or anti- anxiety agent in the central nervous system. Folic acid is used for the mechanism of blood glucose control. It is essential because glucose causes high levels of oxidative stress throughout the body. In antioxidant therapy folic acid is very important antioxidant to help prevent neuropathy and Methylcobalamin is used in the treatment of diabetic neuropathy, it is a form of vitamin B12. Methylcobalamin are necessary to correct neurological defects. This combination can provide relief in infections on the feet and legs, in multiple fractures of the knee, ankle or foot, a Charcot joint as well as loss of motor function resulting in dorsiflexion, contractures of the toes, loss of the interosseous muscle function and contraction of the digits, so called hammer toes, loss of the musculature making the hand appear gaunt and skeletal and the loss of muscular function.</p>
申请公布号 WO2013108262(A1) 申请公布日期 2013.07.25
申请号 WO2012IN00044 申请日期 2012.01.18
申请人 ZOTA HEALTH CARE LTD;ZOTA, KAMLESH RAJNIKANT;AGRAWAL, SANJAY;ZOTA, KETAN CHANDULAL;ZOTA, MANUKANT CHANDULAL;ZOTA, HIMANSHU MUKTILAL 发明人 ZOTA, KAMLESH RAJNIKANT;AGRAWAL, SANJAY;ZOTA, KETAN CHANDULAL;ZOTA, MANUKANT CHANDULAL;ZOTA, HIMANSHU MUKTILAL
分类号 A61K31/185;A61K31/519;A61K31/714;A61P25/00 主分类号 A61K31/185
代理机构 代理人
主权项
地址